Affinivax was acquired by GSK in August 2022. Affinivax is a clinical stage biotechnology company developing a next generation approach in vaccine technologies to design both preventive and therapeutic vaccines that provide broader protection against infectious and other immune mediated diseases.

CARB-X

EcoR1 Capital

Foresite Capital

Wellington Management

Ziff Capital Partners

Rock Springs Capital

Logos Capital

Surveyor Capital

T. Rowe Price

Viking Global Investors

Affinivax Inc.

Affiniax Partners is a team of experienced accounting and business advisory professionals with extensive experience in the UAE and Global markets. They are early adopters and drivers of change in a rapidly evolving modern market, providing services such as accounting, audit, cloud accounting, business advisory, tax consultancy, and more.

Affiniax Partners

COM:AFFINIVAX

Affiniax Partners

Filings Not Available